Augur Signals: News Feed

Latest Investment Activity Reports

Alerts , Utilities , Utilities—Regulated Water , CDZI

Insider Transaction Report: Cadiz Inc. (CDZI)

  • Acquired: Non-Derivative
Insider Transaction Report: Cadiz Inc. (CDZI)
On January 4, 2024, Susan P. Kennedy, Executive Director of Cadiz Inc., purchased 6,762 shares at $2.81 per share, increasing her stake to 91,921 shares. Over the past year, Kennedy's consistent investment in CDZI shares, including significant purchases in September and December, signals her confidence in the company's future. Despite market volatility, with price changes ranging from a -13.55% decrease to a 5.9% increase over various periods, Kennedy's actions could indicate a belief in the stock's undervaluation or potential growth. Cadiz Inc. operates in the regulated water industry and has a market capitalization of USD 179,808,128.00. Kennedy's …
Alerts , Utilities , Utilities—Regulated Water , CDZI

Cadiz Inc. Insider Transaction Analysis

  • Acquired: Non-Derivative
Cadiz Inc. Insider Transaction Analysis

On January 4, 2024, Susan P Kennedy, an insider at Cadiz Inc. (CDZI), bought 6,762 shares at $2.81 each, totaling $18,798.36. Kennedy's ownership increased to 91,921 shares. As Executive Director since June 30, 2021, her consistent purchases suggest confidence in the company. Despite recent volatility, with a ten-day average of $3.02 and a fifty-day increase of 2.96%, her actions may indicate positive prospects for Cadiz Inc. Investors should note these insider transactions when considering the company’s market position.

Alerts , Healthcare , Biotechnology , KALV

Insider Trading Analysis: Venrock Healthcare Capital Partners III L.P.'s Latest Acquisition in KalVista Pharmaceuticals, Inc.

  • Acquired: Non-Derivative
Insider Trading Analysis: Venrock Healthcare Capital Partners III L.P.'s Latest Acquisition in KalVista Pharmaceuticals, Inc.
On January 4, 2024, Venrock Healthcare Capital Partners III, L.P. purchased 41,764 shares of KalVista Pharmaceuticals, Inc. (KALV) at $12.11 per share, increasing their holdings to 4,152,100 shares valued at $489,891.70. This insider has consistently shown confidence in KALV, with a history of stock purchases, such as the acquisition of 471,490 shares at $12.50 each, totaling $5,695,599.16. KalVista, in the Biotechnology sector, has experienced market volatility but also significant price appreciation over the last 200 days. The insider's actions suggest a bullish outlook, aligning with the stock's positive momentum and the company's clinical advancements. Investors are encouraged to …
Alerts , Technology , Software—Infrastructure , SNPS

Insider Transaction Report: Synopsys, Inc.

  • Disposed: Non-Derivative
Insider Transaction Report: Synopsys, Inc.

On January 3, 2024, Mahoney Richard S., Chief Revenue Officer of Synopsys, Inc., sold 4,424 shares at $494.68 each, totalling $2,178,377.57. This reflects direct ownership change. Historically, Mahoney has been active in the market, with transactions including both acquisitions and disposals. Synopsys has a strong market presence with a 45.66% year-over-year stock increase, despite a recent dip. The company boasts a market cap of USD 71,120,560,128.00 and solid liquidity. Insider activities, such as those by Johnson Mercedes and John F Jr Runkel, also provide market insights.

Alerts , Healthcare , Biotechnology , VANI

Insider Transaction Spotlight: Williams Gregg's Recent Acquisition in Vivani Medical, Inc.

  • Acquired: Non-Derivative
Insider Transaction Spotlight: Williams Gregg's Recent Acquisition in Vivani Medical, Inc.

On January 3, 2024, Williams Gregg, a significant insider of Vivani Medical, Inc. (Ticker: VANI), purchased 3,563 shares at $1.01 per share. This investment increased Gregg's holdings to 686,717 shares, totaling about $3,669.89. As a director and ten percent owner, Gregg's consistent stock acquisitions highlight his confidence in the company's future.

Vivani Medical, Inc., in the Biotechnology industry, focuses on innovative medical devices. Despite a challenging market with a 52-week price drop of -82.12%, Gregg's actions suggest a positive outlook. The company's market capitalization stands at USD 50,818,800.00, with cash reserves …

Pages total: 46